Daniel M. Bendheim, Executive VP, Corporate Strategy at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 7,820 shares at $40.06 ($313K) on 2018-03-05, disclosed to the SEC on 2018-03-07.
Open-market sale of $313k PAHC by Executive VP, Corporate Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.06 | 3,860 | $155K | 49.4% |
| 2 | $40.06 | 3,860 | $155K | 49.4% |
| 3 | $40.15 | 100 | $4K | 1.3% |
| Total | $40.06 avg | 7,820 | $313K | 100% |
| Filing → |
| PAHC | SELL | 2019-01-18 | $242K | — | Filing → |
| PAHC | SELL | 2019-01-10 | $162K | — | Filing → |
| PAHC | SELL | 2019-01-07 | $238K | — | Filing → |